insights_auto
Pse është ulur EVGN 4,09%?
Zhytu më thellëchevron_right
EVGN:NASDAQ
Evogene Ltd
0,38 US$
arrow_downward
-4,09%(-0,016) 1D
9 tet, 4:00:00 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për EVGN...
Hap
0,39 US$
I lartë
0,39 US$
I ulët
0,37 US$
Kapitalizimi i tregut
6,90 mln
Vëllimi mesatar
2,57 mln
Vëllimi
0,00
Maksimumi 52-javor
1,49 US$
Minimumi 52-javor
0,35 US$
Fitimet për aksion
-0,90 US$
Beta
1,44
Aksionet në qarkullim
18,05 mln
Numri i punonjësve
52
Hap
0,39 US$
I lartë
0,39 US$
I ulët
0,37 US$
Kapitalizimi i tregut
6,90 mln
Vëllimi mesatar
2,57 mln
Vëllimi
0,00
Maksimumi 52-javor
1,49 US$
Minimumi 52-javor
0,35 US$
Fitimet për aksion
-0,90 US$
Beta
1,44
Aksionet në qarkullim
18,05 mln
Numri i punonjësve
52
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Investing.com Nigeria
·
14 orë më parë
Form 13D/A Evogene Ltd. For: 11 October By Investing.com
Profili
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Rreth Evogene Ltd